Physician
Geo Medical Care PC
Geo Medical Care PC was paid $9.79M by Medicaid between Jan 2018 and Dec 2024, across 84 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoGEO MEDICAL CARE PC
BROOKLYN, NY 11226
BROOKLYN, NY 11226
33aNPI1487655031assigned 08/04/2005
33bProvider typeInternal Medicine Physician
28Total paid$9.79M
24GClaims340,126
24DCodes billed84
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#27 of 6,049
Median peer was paid$11K
This provider vs. median865×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,865 | $1.21M | |
| 2019 | 50,531 | $1.28M | |
| 2020 | 35,564 | $881K | |
| 2021 | 50,609 | $1.06M | |
| 2022 | 62,544 | $1.79M | |
| 2023 | 47,462 | $1.74M | |
| 2024incomplete | 50,551 | $1.83M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 74,474 | 60,829 | $4.90M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.5% | 18,045 | 16,509 | $729K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.1% | 6,081 | 5,801 | $598K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.8% | 19,285 | 18,897 | $564K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3.6% | 3,159 | 3,039 | $355K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.5% | 6,267 | 6,222 | $346K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 3.3% | 17,245 | 16,473 | $323K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.0% | 5,016 | 4,972 | $298K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.4% | 4,461 | 4,370 | $230K |
| 99188 | 1.7% | 10,256 | 10,216 | $168K | |
| 99441 | 1.6% | 4,506 | 4,169 | $159K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 2,190 | 2,132 | $128K |
72 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 1,679 | $120K |
| 92551 | 1.2% | 15,292 | $113K | |
| 90461 | <1% | 4,048 | $93K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 9,146 | $79K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,568 | $59K |
| 99051 | <1% | 18,549 | $57K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 4,186 | $47K |
| 83655 | <1% | 4,855 | $45K | |
| 94010 | <1% | 1,204 | $36K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,346 | $33K |
| 92567 | <1% | 2,411 | $32K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 354 | $31K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 4,441 | $23K |
| 99050 | <1% | 4,230 | $22K | |
| 99177 | <1% | 11,204 | $14K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,180 | $14K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 154 | $14K |
| 99406 | <1% | 3,918 | $13K | |
| 0001A | <1% | 425 | $13K | |
| 0072A | <1% | 322 | $12K | |
| 0002A | <1% | 386 | $12K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,195 | $11K |
| 0071A | <1% | 285 | $10K | |
| 90658 | <1% | 4,300 | $10K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 5,170 | $8K |
| 99401 | <1% | 1,078 | $7K | |
| 99072 | <1% | 23,519 | $7K | |
| 92552 | <1% | 225 | $6K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 192 | $6K |
| 99381 | <1% | 53 | $4K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 31 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 212 | $4K |
| 0003A | <1% | 98 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 270 | $4K |
| 94060 | <1% | 54 | $3K | |
| 90677 | <1% | 361 | $2K | |
| 90651 | <1% | 973 | $2K | |
| 90716 | <1% | 1,089 | $2K | |
| 90715 | <1% | 384 | $1K | |
| 90707 | <1% | 1,121 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 131 | $1K |
| 90656 | <1% | 325 | $1K | |
| 90674 | <1% | 174 | $825.43 | |
| 90480 | <1% | 29 | $632.19 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 38 | $558.49 |
| 0124A | <1% | 15 | $550.13 | |
| 69210 | <1% | 14 | $363.76 | |
| 99174 | <1% | 863 | $361.43 | |
| 99173 | <1% | 801 | $338.40 | |
| 90474 | <1% | 43 | $300.18 | |
| 92570 | <1% | 14 | $297.22 | |
| 90734 | <1% | 796 | $277.75 | |
| 86580 | <1% | 28 | $244.57 | |
| 90633 | <1% | 1,134 | $141.89 | |
| 97802 | <1% | 43 | $137.92 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 148 | $133.08 |
| A7014 | Filter, nondisposable, used with aerosol compressor or ultrasonic generator | <1% | 143 | $92.44 |
| 90672 | <1% | 301 | $82.61 | |
| 90657 | <1% | 674 | $56.40 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 105 | $50.00 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 109 | $43.66 |
| 90648 | <1% | 1,336 | $35.95 | |
| 90670 | <1% | 1,307 | $17.99 | |
| 91300 | <1% | 611 | $6.78 | |
| 90700 | <1% | 707 | $0.43 | |
| 91307 | <1% | 599 | $0.17 | |
| 90723 | <1% | 820 | $0.15 | |
| 90713 | <1% | 384 | $0.09 | |
| 90686 | <1% | 278 | $0.08 | |
| 90680 | <1% | 767 | $0.07 | |
| 3023F | 0% | 56 | $0.00 | |
| 99000 | 0% | 9,840 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKHAN, NASRULLAH (OWNER)